Wa'el Hashad is the Executive Vice President and Chief Commercial Officer of Seres Therapeutics, Inc. ("Seres"). He has over 20 years of experience as a commercial leader and has held senior marketing and general management positions in the pharmaceutical and biotechnology industry throughout his career. Prior to joining Seres, he served as Regional General Manager for Middle East and Africa at Amgen. Prior to that he served as Head of Global Marketing for General Medicine. Prior to Amgen, Wa’el worked at Boehringer Ingelheim and Eli Lilly where he launched several products in the US, most notably Pradaxa® and Cymbalta®. Wa’el brings significant sales, marketing, market access, and diverse therapeutic expertise in both the US and international markets. He earned his undergraduate degree from College of Pharmacy Cairo University and his MBA from the University of Akron, Ohio.